121 related articles for article (PubMed ID: 22547413)
1. The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--commentary.
Hutchinson M
Mult Scler; 2012 May; 18(5):561-2. PubMed ID: 22547413
[No Abstract] [Full Text] [Related]
2. The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--no.
Filippi M; Rocca MA
Mult Scler; 2012 May; 18(5):557-8. PubMed ID: 22547411
[No Abstract] [Full Text] [Related]
3. The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--yes.
Geurts JJ
Mult Scler; 2012 May; 18(5):559-60. PubMed ID: 22547412
[No Abstract] [Full Text] [Related]
4. What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque.
Hartel M; Kluczewska E; Pierzchała K; Adamczyk-Sowa M; Karpe J
Neurol Neurochir Pol; 2016; 50(2):123-30. PubMed ID: 26969569
[TBL] [Abstract][Full Text] [Related]
5. MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
Jacobsen CO; Farbu E
Acta Neurol Scand Suppl; 2014; (198):32-6. PubMed ID: 24588504
[TBL] [Abstract][Full Text] [Related]
6. Challenges in multiple sclerosis; how to define occurence of progression.
Brinar VV; Barun B
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S30-4. PubMed ID: 24321151
[TBL] [Abstract][Full Text] [Related]
7. [Relaxation-time measurements of the white and gray substances in multiple sclerosis patients].
Rinck PA; Appel B; Moens E
Rofo; 1987 Dec; 147(6):661-3. PubMed ID: 2827261
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging in multiple sclerosis: the role of conventional imaging.
Sicotte NL
Neurol Clin; 2011 May; 29(2):343-56. PubMed ID: 21439445
[TBL] [Abstract][Full Text] [Related]
9. Relaxation times of apparently normal cerebral white matter in multiple sclerosis.
Ormerod IE; Johnson G; MacManus D; du Boulay EP; McDonald WI
Acta Radiol Suppl; 1986; 369():382-4. PubMed ID: 2980503
[TBL] [Abstract][Full Text] [Related]
10. [MRI and the diagnosis of multiple sclerosis].
Lyrer P; Groebke-Lorenz W; Benz UF; Wüthrich R
Schweiz Med Wochenschr; 1989 Dec; 119(51):1849-53. PubMed ID: 2609142
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis.
Zivadinov R; Zorzon M; Weinstock-Guttman B; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):620-5. PubMed ID: 19168469
[TBL] [Abstract][Full Text] [Related]
12. [In-vivo assessment of multiple sclerosis pathology: the role of neuroimaging techniques].
Comi G; Rovaris M; Filippi M
Rev Neurol; 2000 Jun 16-30; 30(12):1218-23. PubMed ID: 10935254
[TBL] [Abstract][Full Text] [Related]
13. The role of magnetic resonance imaging in the study of multiple sclerosis: diagnosis, prognosis and understanding disease pathophysiology.
Filippi M; Rocca MA
Acta Neurol Belg; 2011 Jun; 111(2):89-98. PubMed ID: 21748926
[TBL] [Abstract][Full Text] [Related]
14. MRI in multiple sclerosis.
Simon JH
Phys Med Rehabil Clin N Am; 2005 May; 16(2):383-409, viii. PubMed ID: 15893678
[TBL] [Abstract][Full Text] [Related]
15. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
16. MS researchers assess MRI as outcome tool.
Carswell H
Diagn Imaging (San Franc); 1996 May; 18(5):49-51, 53-4, 56. PubMed ID: 10160445
[No Abstract] [Full Text] [Related]
17. [Contribution of nuclear magnetic resonance imaging in multiple sclerosis].
Ranjeva JP; Audoin B; Pelletier J; Confavreux C
Rev Prat; 2006 Jun; 56(12):1326-35. PubMed ID: 16948221
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of grey matter damage in people with MS.
Filippi M; Valsasina P; Rocca M
Int MS J; 2007 Mar; 14(1):12-21. PubMed ID: 17509248
[TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance and multiple sclerosis I. Conventional diagnostic techniques].
Mathiesen HK; Langkilde AR; Larsson HB
Ugeskr Laeger; 2002 Feb; 164(8):1026-31. PubMed ID: 11894702
[TBL] [Abstract][Full Text] [Related]
20. Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
Petracca M; Vancea RO; Fleysher L; Jonkman LE; Oesingmann N; Inglese M
Brain; 2016 Mar; 139(Pt 3):795-806. PubMed ID: 26792552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
